RSS
Press Releases
Trusted reliable news sources from around the web. We offer special news reports, topic news videos, and related content stories. Truly a birds eye view on news.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
AMSTERDAM, June 15, 2026 (GLOBE NEWSWIRE) -- Het Consumer Choice Center lanceerde in Amsterdam een mobiele publiekscampagne met een op een vrachtwagen gemonteerd lcd-scherm om de vrijheid van meningsuiting en het recht van consumenten om gehoord te worden in het publieke debat te verdedigen.
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
MIAMI, June 15, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs today announced the launch of the Defiance Daily Target 2X Long SpaceX ETF (Cboe: SPCU). SPCU begins trading today at 4am ET and seeks daily investment results, before fees and expenses, equal to 200% of the daily performance of SpaceX Class A common stock (NASDAQ: SPCX).
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
NEW YORK, June 14, 2026 (GLOBE NEWSWIRE) -- GROWNSY, a baby care innovator trusted by over 3 million households globally, is honored to announce that their Portable Bottle Warmer and SniffEase Spa 3-in-1 Nasal Aspirator have both earned the prestigious Mom’s Choice Award®. Having been rigorously evaluated by a panel of MCA evaluators, the Portable…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
VANCOUVER, British Columbia, June 14, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today presented new clinical data from the dose-escalation portion of its ongoing Phase 1 study evaluating ZW191, a folate receptor alpha (FRα)-targeting antibody-drug…
- Details
- Written by Globe NewsWire Press Releases
- Category: Globe NewsWire News Distribution Service
Data from up to two years of treatment in PATHFNDR-1 and PATHFNDR-2 open-label extension studies show PALSONIFY maintained lower IGF-1 levels and stable symptoms Treatment also resulted in stable or reduced pituitary tumor volumes for up to 48 weeks
Globe NewsWire News Distribution Service Article Count: 1561
Media Partner Network Article Count: 4
Send2Press NewsWire Distribution Service Article Count: 541
Related Product Search/Búsqueda de productos relacionados
